Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Renal Failure

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 244 articles:
HTML format
Text format



Single Articles


    June 2018
  1. LANDWEHR-KENZEL S, Zobel A, Hoffmann H, Landwehr N, et al
    Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy.
    Kidney Int. 2018;93:1452-1464.
    PubMed     Text format     Abstract available


  2. WYATT CM, Wanner N
    Gone but not forgotten: resolution of childhood kidney disease and the risk of end-stage kidney disease in adults.
    Kidney Int. 2018;93:1260-1262.
    PubMed     Text format    


    May 2018
  3. ALEKSOVA J, Wong P, McLachlan R, Choy KW, et al
    Sex hormone-binding globulin is a biomarker associated with nonvertebral fracture in men on dialysis therapy.
    Kidney Int. 2018 May 15. pii: S0085-2538(18)30212.
    PubMed     Text format     Abstract available


  4. SCHAEFER B, Bartosova M, Macher-Goeppinger S, Sallay P, et al
    Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.
    Kidney Int. 2018 May 15. pii: S0085-2538(18)30213.
    PubMed     Text format     Abstract available


  5. ALRIC L, Ollivier-Hourmand I, Berard E, Hillaire S, et al
    Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective.
    Kidney Int. 2018 May 5. pii: S0085-2538(18)30209.
    PubMed     Text format     Abstract available


  6. NG DK, Schwartz GJ, Schneider MF, Furth SL, et al
    Combination of pediatric and adult formulas yield valid glomerular filtration rate estimates in young adults with a history of pediatric chronic kidney disease.
    Kidney Int. 2018 May 5. pii: S0085-2538(18)30184.
    PubMed     Text format     Abstract available


  7. GOODKIN DA, Bieber B
    International prevalence of hepatitis C positivity among hemodialysis patients awaiting transplantation.
    Kidney Int. 2018;93:1249.
    PubMed     Text format    


  8. FUSARO M, Cannata-Andia JB, Nickolas TL, Plebani M, et al
    Clinical relevance and future perspective of fractures in patients with chronic kidney disease.
    Kidney Int. 2018;93:1248.
    PubMed     Text format    


  9. STENGEL B
    Uncovering real mortality trends in ESRD patients.
    Kidney Int. 2018;93:1040-1043.
    PubMed     Text format     Abstract available


    April 2018
  10. NEVEN E, Vervaet B, Brand K, Gottwald-Hostalek U, et al
    Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Kidney Int. 2018 Apr 28. pii: S0085-2538(18)30174.
    PubMed     Text format     Abstract available


  11. BARUTTA F, Bruno G, Mastrocola R, Bellini S, et al
    The role of cannabinoid signaling in acute and chronic kidney diseases.
    Kidney Int. 2018 Apr 26. pii: S0085-2538(18)30140.
    PubMed     Text format     Abstract available


  12. BRUCK K, Jager KJ, Zoccali C, Bello AK, et al
    Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe.
    Kidney Int. 2018 Apr 12. pii: S0085-2538(18)30096.
    PubMed     Text format     Abstract available


  13. KALRA PA, Green D, Poulikakos D
    Arrhythmia in hemodialysis patients and its relation to sudden death.
    Kidney Int. 2018;93:781-783.
    PubMed     Text format     Abstract available


  14. LABRIOLA L, Jadoul M
    Taurolidine-based lock solutions for hemodialysis catheters: the enthusiasm should be tempered.
    Kidney Int. 2018;93:1015-1016.
    PubMed     Text format    


  15. MATHEW RO, Bangalore S, Sidhu MS, Fleg JL, et al
    Increasing inclusion of patients with advanced chronic kidney disease in cardiovascular clinical trials.
    Kidney Int. 2018;93:787-788.
    PubMed     Text format    


  16. WATERS DD, Vogt L
    Lipids, inflammation, and chronic kidney disease: a SHARP perspective.
    Kidney Int. 2018;93:784-786.
    PubMed     Text format     Abstract available


  17. PRASAD PV
    Update on renal blood oxygenation level-dependent MRI to assess intrarenal oxygenation in chronic kidney disease.
    Kidney Int. 2018;93:778-780.
    PubMed     Text format     Abstract available


  18. GRAUDAL N
    U-shaped dietary sodium-associated incidence of chronic kidney disease cautions against salt overrestriction in hypertension.
    Kidney Int. 2018;93:776-778.
    PubMed     Text format     Abstract available


  19. OOMATIA A, Dupont P, Bass P, Moochhala S, et al
    The Case | Shining a light on an unusual case of chronic kidney disease.
    Kidney Int. 2018;93:1023-1024.
    PubMed     Text format    


    March 2018
  20. GRAMS ME, Sang Y, Ballew SH, Carrero JJ, et al
    Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate.
    Kidney Int. 2018 Mar 24. pii: S0085-2538(18)30097.
    PubMed     Text format     Abstract available


  21. VERVLOET MG, van Ballegooijen AJ
    Prevention and treatment of hyperphosphatemia in chronic kidney disease.
    Kidney Int. 2018 Mar 23. pii: S0085-2538(18)30124.
    PubMed     Text format     Abstract available


  22. WANG J, Zhang L, Tang SC, Kashihara N, et al
    Disease burden and challenges of chronic kidney disease in North and East Asia.
    Kidney Int. 2018 Mar 21. pii: S0085-2538(18)30094.
    PubMed     Text format    


  23. PUN PH, Wyatt CM
    Utility of implantable cardioverter defibrillators in chronic kidney disease.
    Kidney Int. 2018 Mar 17. pii: S0085-2538(18)30196.
    PubMed     Text format    


  24. BATAL I, Mohan S, De Serres SA, Vasilescu ER, et al
    Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes.
    Kidney Int. 2018 Mar 13. pii: S0085-2538(18)30059.
    PubMed     Text format     Abstract available


  25. TOTH PP, Dwyer JP, Cannon CP, Colhoun HM, et al
    Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease.
    Kidney Int. 2018 Mar 8. pii: S0085-2538(18)30055.
    PubMed     Text format     Abstract available


  26. TONELLI M, Wiebe N, James MT, Klarenbach SW, et al
    A population-based cohort study defines prognoses in severe chronic kidney disease.
    Kidney Int. 2018 Mar 7. pii: S0085-2538(18)30057.
    PubMed     Text format     Abstract available


    February 2018
  27. RABBANI N, Thornalley PJ
    Advanced glycation end products in the pathogenesis of chronic kidney disease.
    Kidney Int. 2018 Feb 22. pii: S0085-2538(18)30051.
    PubMed     Text format     Abstract available


  28. KOPP C, Linz P, Maier C, Wabel P, et al
    Elevated tissue sodium deposition in patients with type 2 diabetes on hemodialysis detected by (23)Na magnetic resonance imaging.
    Kidney Int. 2018 Feb 15. pii: S0085-2538(17)30857.
    PubMed     Text format     Abstract available


  29. SUMIDA K, Molnar MZ, Potukuchi PK, Hassan F, et al
    Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease.
    Kidney Int. 2018 Feb 3. pii: S0085-2538(17)30893.
    PubMed     Text format     Abstract available


  30. NITSCH D
    Does dialysis modality affect the development of cognitive impairment?
    Kidney Int. 2018;93:306-308.
    PubMed     Text format     Abstract available


  31. DUSSO A, Colombo MI, Shanahan CM
    Not all vascular smooth muscle cell exosomes calcify equally in chronic kidney disease.
    Kidney Int. 2018;93:298-301.
    PubMed     Text format     Abstract available


  32. ORDUNEZ P, Hoy WE
    Case definitions and approaches for surveillance of chronic kidney disease in agricultural communities in Central America: policy implications.
    Kidney Int. 2018;93:284-287.
    PubMed     Text format    


    January 2018
  33. STOREY BC, Staplin N, Harper CH, Haynes R, et al
    Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.
    Kidney Int. 2018 Jan 30. pii: S0085-2538(17)30856.
    PubMed     Text format     Abstract available


  34. ROY-CHAUDHURY P, Tumlin JA, Koplan BA, Costea AI, et al
    Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle.
    Kidney Int. 2018 Jan 27. pii: S0085-2538(17)30855.
    PubMed     Text format     Abstract available


  35. DOU L, Poitevin S, Sallee M, Addi T, et al
    Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.
    Kidney Int. 2018 Jan 22. pii: S0085-2538(17)30826.
    PubMed     Text format     Abstract available


  36. LIU BC, Tang TT, Lv LL, Lan HY, et al
    Renal tubule injury: a driving force toward chronic kidney disease.
    Kidney Int. 2018 Jan 17. pii: S0085-2538(17)30819.
    PubMed     Text format     Abstract available


  37. PRUIJM M, Milani B, Pivin E, Podhajska A, et al
    Reduced cortical oxygenation predicts a progressive decline of renal function in patients with chronic kidney disease.
    Kidney Int. 2018 Jan 9. pii: S0085-2538(17)30800.
    PubMed     Text format     Abstract available


  38. LEE BJ, Go AS, Parikh R, Leong TK, et al
    Pre-admission proteinuria impacts risk of non-recovery after dialysis-requiring acute kidney injury.
    Kidney Int. 2018 Jan 9. pii: S0085-2538(17)30797.
    PubMed     Text format     Abstract available


  39. PERSSON F, Borg R
    YKL-40 in dialysis patients: another candidate in the quest for useful biomarkers in nephrology.
    Kidney Int. 2018;93:21-22.
    PubMed     Text format     Abstract available


  40. MARSHALL MR
    Intensive hemodialysis-keeping the faith.
    Kidney Int. 2018;93:10-12.
    PubMed     Text format     Abstract available


  41. RODELO-HAAD C, Aguera ML, Ortega R, Martinez-Lopez A, et al
    Lithium-associated nephropathy in the renal allograft.
    Kidney Int. 2018;93:273.
    PubMed     Text format    


  42. ETTA PK, Rao MV
    Gas in a renal allograft: think beyond!
    Kidney Int. 2018;93:272.
    PubMed     Text format    


  43. FARRAH TE, Anand A, Miller-Hodges E, Mills NL, et al
    Endothelin antagonism reduces circulating galectin-3 in patients with proteinuric chronic kidney disease.
    Kidney Int. 2018;93:270.
    PubMed     Text format    


    December 2017
  44. YU ASL, Shen C, Landsittel DP, Harris PC, et al
    Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
    Kidney Int. 2017 Dec 28. pii: S0085-2538(17)30785.
    PubMed     Text format     Abstract available


  45. ANDERS HJ, Suarez-Alvarez B, Grigorescu M, Foresto-Neto O, et al
    The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury.
    Kidney Int. 2017 Dec 11. pii: S0085-2538(17)30772.
    PubMed     Text format     Abstract available


  46. LI J, Basler M, Alvarez G, Brunner T, et al
    Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
    Kidney Int. 2017 Dec 4. pii: S0085-2538(17)30773.
    PubMed     Text format     Abstract available



  47. Moradi H, Said HM. Functional thiamine deficiency in end-stage renal disease: malnutrition despite ample nutrients. Kidney Int. 2016;90:252-254.
    Kidney Int. 2017;92:1558.
    PubMed     Text format    



  48. Li L, Lai EY, Luo Z, et al. Superoxide and hydrogen peroxide counterregulate myogenic contractions in renal afferent arterioles from a mouse model of chronic kidney disease. Kidney Int. 2017;92:625-633.
    Kidney Int. 2017;92:1558.
    PubMed     Text format    



  49. Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. Kidney Int. 2017;92:26-36.
    Kidney Int. 2017;92:1558.
    PubMed     Text format    


  50. ISAKA Y
    Adaptor protein is a new therapeutic target in chronic kidney disease.
    Kidney Int. 2017;92:1312-1314.
    PubMed     Text format     Abstract available


    November 2017
  51. YOON CY, Noh J, Lee J, Kee YK, et al
    High and low sodium intakes are associated with incident chronic kidney disease in patients with normal renal function and hypertension.
    Kidney Int. 2017 Nov 29. pii: S0085-2538(17)30764.
    PubMed     Text format     Abstract available


  52. WAGENSEIL JE
    Does elastin deficiency cause chronic kidney disease?
    Kidney Int. 2017;92:1036-1038.
    PubMed     Text format     Abstract available


  53. LIN TY, Peng CH, Hung SC, Tarng DC, et al
    Body composition is associated with clinical outcomes in patients with non-dialysis-dependent chronic kidney disease.
    Kidney Int. 2017 Nov 1. pii: S0085-2538(17)30663.
    PubMed     Text format     Abstract available


    October 2017
  54. SAWINSKI D, Forde KA, Locke JE, Cohen JB, et al
    Race but not Hepatitis C co-infection affects survival of HIV+ individuals on dialysis in contemporary practice.
    Kidney Int. 2017 Oct 26. pii: S0085-2538(17)30612.
    PubMed     Text format     Abstract available


  55. NEUMANN D, Mau W, Wienke A, Girndt M, et al
    Peritoneal dialysis is associated with better cognitive function than hemodialysis over a one-year course.
    Kidney Int. 2017 Oct 14. pii: S0085-2538(17)30568.
    PubMed     Text format     Abstract available


  56. CHARYTAN DM, Skali H, Shah NR, Veeranna V, et al
    Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage.
    Kidney Int. 2017 Oct 13. pii: S0085-2538(17)30571.
    PubMed     Text format     Abstract available


  57. TURNER JM, Peixoto AJ
    Blood pressure targets for hemodialysis patients.
    Kidney Int. 2017;92:816-823.
    PubMed     Text format     Abstract available


  58. STREJA E
    Hospital readmission for the dialysis patient: who is (not) responsible?
    Kidney Int. 2017;92:788-790.
    PubMed     Text format     Abstract available


    September 2017
  59. PIMENTEL A, Urena-Torres P, Zillikens MC, Bover J, et al
    Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Kidney Int. 2017 Sep 27. pii: S0085-2538(17)30567.
    PubMed     Text format     Abstract available


  60. LORENZ G, Schmalenberg M, Kemmner S, Haller B, et al
    Mortality prediction in stable hemodialysis patients is refined by YKL-40, a 40-kDa glycoprotein associated with inflammation.
    Kidney Int. 2017 Sep 20. pii: S0085-2538(17)30540.
    PubMed     Text format     Abstract available


  61. GALVAN DL, Green NH, Danesh FR
    The hallmarks of mitochondrial dysfunction in chronic kidney disease.
    Kidney Int. 2017 Sep 8. pii: S0085-2538(17)30505.
    PubMed     Text format     Abstract available


  62. WINNICKI W, Herkner H, Lorenz M, Handisurya A, et al
    Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
    Kidney Int. 2017 Sep 7. pii: S0085-2538(17)30495.
    PubMed     Text format     Abstract available


  63. MENGEL M
    Deconstructing interstitial fibrosis and tubular atrophy: a step toward precision medicine in renal transplantation.
    Kidney Int. 2017;92:553-555.
    PubMed     Text format     Abstract available


  64. LUCAS GM
    Association between hepatitis C virus and chronic kidney disease: heterogeneity begets heterogeneity.
    Kidney Int. 2017;92:546-548.
    PubMed     Text format     Abstract available


    August 2017
  65. REBHOLZ CM, Selvin E, Liang M, Ballantyne CM, et al
    Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.
    Kidney Int. 2017 Aug 30. pii: S0085-2538(17)30497.
    PubMed     Text format     Abstract available


  66. TENNANKORE KK, Na Y, Wald R, Chan CT, et al
    Short daily-, nocturnal- and conventional-home hemodialysis have similar patient and treatment survival.
    Kidney Int. 2017 Aug 23. pii: S0085-2538(17)30467.
    PubMed     Text format     Abstract available


  67. WILLIAMS MJ, Sugatani T, Agapova OA, Fang Y, et al
    The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.
    Kidney Int. 2017 Aug 23. pii: S0085-2538(17)30476.
    PubMed     Text format     Abstract available


  68. TOMLINSON JAP, Wheeler DC
    The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease.
    Kidney Int. 2017 Aug 11. pii: S0085-2538(17)30397.
    PubMed     Text format     Abstract available


  69. AUFRICHT C, Beelen R, Eberl M, Fischbach M, et al
    Biomarker research to improve clinical outcomes of peritoneal dialysis: consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network.
    Kidney Int. 2017 Aug 8. pii: S0085-2538(17)30419.
    PubMed     Text format     Abstract available


  70. ROBERTS DM, Lea-Henry TN
    Simplifying the hemodialysis prescription in patients with ethylene glycol poisoning.
    Kidney Int. 2017;92:291-293.
    PubMed     Text format     Abstract available


  71. KAMAL F, Khan MA, Howden CW
    Proton pump inhibitors and chronic kidney disease.
    Kidney Int. 2017;92:515.
    PubMed     Text format    


  72. WYATT CM, Drueke TB
    Vascular calcification in chronic kidney disease: here to stay?
    Kidney Int. 2017;92:276-278.
    PubMed     Text format     Abstract available


    July 2017
  73. SHINOZAKI Y, Furuichi K, Toyama T, Kitajima S, et al
    Impairment of the carnitine/organic cation transporter 1-ergothioneine axis is mediated by intestinal transporter dysfunction in chronic kidney disease.
    Kidney Int. 2017 Jul 26. pii: S0085-2538(17)30332.
    PubMed     Text format     Abstract available


  74. NAVANEETHAN SD, Schold JD, Jolly SE, Arrigain S, et al
    Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30327.
    PubMed     Text format     Abstract available


  75. RITTER C, Miller B, Coyne DW, Gupta D, et al
    Paricalcitol and cinacalcet have disparate actions on parathyroid oxyphil cell content in patients with chronic kidney disease.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30326.
    PubMed     Text format     Abstract available


  76. HARAMBAT J, Kunzmann K, Azukaitis K, Bayazit AK, et al
    Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease.
    Kidney Int. 2017 Jul 17. pii: S0085-2538(17)30330.
    PubMed     Text format     Abstract available


  77. GALSGAARD J, Persson F, Hansen TW, Jorsal A, et al
    Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Kidney Int. 2017 Jul 13. pii: S0085-2538(17)30310.
    PubMed     Text format     Abstract available


  78. KENTRUP D, Bovenkamp P, Busch A, Schuette-Nuetgen K, et al
    GlucoCEST magnetic resonance imaging in vivo may be diagnostic of acute renal allograft rejection.
    Kidney Int. 2017 Jul 11. pii: S0085-2538(17)30303.
    PubMed     Text format     Abstract available


  79. KORATALA A, Malpartida FR
    Endophthalmitis complicating dialysis access infection.
    Kidney Int. 2017;92:270.
    PubMed     Text format    


  80. TAKEUCHI T, Ohno H, Satoh-Takayama N
    Understanding the immune signature fingerprint of peritoneal dialysis-related peritonitis.
    Kidney Int. 2017;92:16-18.
    PubMed     Text format     Abstract available


  81. KETTELER M, Block GA, Evenepoel P, Fukagawa M, et al
    Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.
    Kidney Int. 2017;92:26-36.
    PubMed     Text format     Abstract available


  82. PERALTA CA, Estrella MM
    Preventive nephrology in the era of "I" evidence: should we screen for chronic kidney disease?
    Kidney Int. 2017;92:19-21.
    PubMed     Text format     Abstract available


    June 2017
  83. JUNO JA, Waruk JLM, Harris A, Mesa C, et al
    gammadelta T-cell function is inhibited in end-stage renal disease and impacted by latent tuberculosis infection.
    Kidney Int. 2017 Jun 24. pii: S0085-2538(17)30241.
    PubMed     Text format     Abstract available


  84. SUGAHARA M, Tanaka T, Nangaku M
    Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease.
    Kidney Int. 2017 Jun 24. pii: S0085-2538(17)30305.
    PubMed     Text format     Abstract available


  85. MARSHALL MR
    Measuring the patient response to dialysis therapy: hemodiafiltration and clinical trials.
    Kidney Int. 2017;91:1279-1282.
    PubMed     Text format     Abstract available


  86. CLAYTON PA, Coates PT
    Are sensitized patients better off with a desensitization transplant or waiting on dialysis?
    Kidney Int. 2017;91:1266-1268.
    PubMed     Text format     Abstract available


  87. ZHANG G, Saito R, Sharma K
    A metabolite-GWAS (mGWAS) approach to unveil chronic kidney disease progression.
    Kidney Int. 2017;91:1274-1276.
    PubMed     Text format     Abstract available


    May 2017
  88. PLANTINGA LC, King L, Patzer RE, Lea JP, et al
    Early hospital readmission among hemodialysis patients in the United States is associated with subsequent mortality.
    Kidney Int. 2017 May 20. pii: S0085-2538(17)30228.
    PubMed     Text format     Abstract available


  89. LAI TS, Lee MH, Yang HI, You SL, et al
    High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease.
    Kidney Int. 2017 May 20. pii: S0085-2538(17)30216.
    PubMed     Text format     Abstract available


  90. LEW QJ, Jafar TH, Talaei M, Jin A, et al
    Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population.
    Kidney Int. 2017 May 18. pii: S0085-2538(17)30214.
    PubMed     Text format     Abstract available


  91. WILD MG, Wallston KA, Green JA, Beach LB, et al
    The Perceived Medical Condition Self-Management Scale can be applied to patients with chronic kidney disease.
    Kidney Int. 2017 May 18. pii: S0085-2538(17)30213.
    PubMed     Text format     Abstract available


  92. LIU X, Yu R, Sun L, Garibotto G, et al
    The nuclear phosphatase SCP4 regulates FoxO transcription factors during muscle wasting in chronic kidney disease.
    Kidney Int. 2017 May 12. pii: S0085-2538(17)30171.
    PubMed     Text format     Abstract available


  93. SUCCAR L, Pianta TJ, Davidson T, Pickering JW, et al
    Subclinical chronic kidney disease modifies the diagnosis of experimental acute kidney injury.
    Kidney Int. 2017 May 2. pii: S0085-2538(17)30170.
    PubMed     Text format     Abstract available


  94. KORATALA A, Chornyy V, Shukla AM, Kazory A, et al
    Tunneled dialysis catheters might receive "permanent resident" status after a while: a case for caution.
    Kidney Int. 2017;91:1259.
    PubMed     Text format    


  95. MJOEN G, Holdaas H
    Regarding "Obesity increases the risk of end-stage renal disease among living kidney donors".
    Kidney Int. 2017;91:1256.
    PubMed     Text format    


  96. DAVENPORT A
    More frequent hemodialysis does not effectively clear protein-bound azotemic solutes derived from gut microbiome metabolism.
    Kidney Int. 2017;91:1008-1010.
    PubMed     Text format     Abstract available


  97. HAAS M
    Simultaneous liver-kidney transplantation: shifting renal allograft gene expression from inflammation toward preservation.
    Kidney Int. 2017;91:1010-1013.
    PubMed     Text format     Abstract available


    April 2017
  98. FERGUSON TW, Tangri N, Tan Z, James MT, et al
    Screening for chronic kidney disease in Canadian indigenous peoples is cost-effective.
    Kidney Int. 2017 Apr 19. pii: S0085-2538(17)30156.
    PubMed     Text format     Abstract available


  99. LIN W, Zhang Q, Liu L, Yin S, et al
    Klotho restoration via acetylation of Peroxisome Proliferation-Activated Receptor gamma reduces the progression of chronic kidney disease.
    Kidney Int. 2017 Apr 14. pii: S0085-2538(17)30158.
    PubMed     Text format     Abstract available


  100. ILIUTA IA, Lachance P, Ghannoum M, Begin Y, et al
    Prediction and validation of the duration of hemodialysis sessions for the treatment of acute ethylene glycol poisoning.
    Kidney Int. 2017 Apr 12. pii: S0085-2538(17)30151.
    PubMed     Text format     Abstract available


  101. MADSEN NL, Goldstein SL, Froslev T, Christiansen CF, et al
    Cardiac surgery in patients with congenital heart disease is associated with acute kidney injury and the risk of chronic kidney disease.
    Kidney Int. 2017 Apr 12. pii: S0085-2538(17)30155.
    PubMed     Text format     Abstract available


  102. HOSHINO J, Larkina M, Karaboyas A, Bieber BA, et al
    Unique hemoglobin A1c level distribution and its relationship with mortality in diabetic hemodialysis patients.
    Kidney Int. 2017 Apr 8. pii: S0085-2538(17)30110.
    PubMed     Text format     Abstract available


  103. SCHAUERTE C, Hubner A, Rong S, Wang S, et al
    Antagonism of profibrotic microRNA-21 improves outcome of murine chronic renal allograft dysfunction.
    Kidney Int. 2017 Apr 8. pii: S0085-2538(17)30117.
    PubMed     Text format     Abstract available


  104. LAW BM, Wilkinson R, Wang X, Kildey K, et al
    Interferon-gamma production by tubulointerstitial human CD56bright natural killer cells contributes to renal fibrosis and chronic kidney disease progression.
    Kidney Int. 2017 Apr 8. pii: S0085-2538(17)30107.
    PubMed     Text format     Abstract available


  105. YAMANOUCHI M, Skupien J, Niewczas MA, Smiles AM, et al
    Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
    Kidney Int. 2017 Apr 7. pii: S0085-2538(17)30112.
    PubMed     Text format     Abstract available


  106. LI L, Lai EY, Luo Z, Solis G, et al
    Superoxide and hydrogen peroxide counterregulate myogenic contractions in renal afferent arterioles from a mouse model of chronic kidney disease.
    Kidney Int. 2017 Apr 7. pii: S0085-2538(17)30111.
    PubMed     Text format     Abstract available


  107. VERMA S, Bassily E, Jarmi T
    An extreme case of tumoral calcinosis in an end-stage renal disease patient.
    Kidney Int. 2017;91:991.
    PubMed     Text format    


  108. IYASERE O, Brown EA
    Cognitive function before and after dialysis initiation in adults with chronic kidney disease-a new perspective on an old problem?
    Kidney Int. 2017;91:784-786.
    PubMed     Text format     Abstract available


  109. WYATT CM
    Decreased incidence of end-stage renal disease in American Indians with diabetes: a model for other high-risk populations?
    Kidney Int. 2017;91:766-768.
    PubMed     Text format     Abstract available


  110. HEINE GH, Brandenburg V
    Anticoagulation, atrial fibrillation, and chronic kidney disease-whose side are you on?
    Kidney Int. 2017;91:778-780.
    PubMed     Text format     Abstract available


  111. BIERZYNSKA A, McCarthy HJ, Soderquest K, Sen ES, et al
    Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.
    Kidney Int. 2017;91:937-947.
    PubMed     Text format     Abstract available


    March 2017
  112. KROLEWSKI AS, Skupien J, Rossing P, Warram JH, et al
    Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes.
    Kidney Int. 2017 Mar 30. pii: S0085-2538(17)30081.
    PubMed     Text format     Abstract available


  113. LAM NN, Tonelli M, Lentine KL, Hemmelgarn B, et al
    Albuminuria and posttransplant chronic kidney disease stage predict transplant outcomes.
    Kidney Int. 2017 Mar 30. pii: S0085-2538(17)30093.
    PubMed     Text format     Abstract available


  114. BRASEN JH, Khalifa A, Schmitz J, Dai W, et al
    Macrophage density in early surveillance biopsies predicts future renal transplant function.
    Kidney Int. 2017 Mar 27. pii: S0085-2538(17)30094.
    PubMed     Text format     Abstract available


  115. KITTISKULNAM P, Chertow GM, Carrero JJ, Delgado C, et al
    Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis.
    Kidney Int. 2017 Mar 16. pii: S0085-2538(17)30082.
    PubMed     Text format     Abstract available


  116. ZHANG J, Friberg IM, Kift-Morgan A, Parekh G, et al
    Machine-learning algorithms define pathogen-specific local immune fingerprints in peritoneal dialysis patients with bacterial infections.
    Kidney Int. 2017 Mar 16. pii: S0085-2538(17)30068.
    PubMed     Text format     Abstract available


  117. ALTMANN C, Ahuja N, Kiekhaefer CM, Andres Hernando A, et al
    Early peritoneal dialysis reduces lung inflammation in mice with ischemic acute kidney injury.
    Kidney Int. 2017 Mar 16. pii: S0085-2538(17)30071.
    PubMed     Text format     Abstract available


  118. MORENA M, Jaussent A, Chalabi L, Leray-Moragues H, et al
    Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly.
    Kidney Int. 2017 Mar 15. pii: S0085-2538(17)30040.
    PubMed     Text format     Abstract available


  119. GRACIOLLI FG, Neves KR, Barreto F, Barreto DV, et al
    The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.
    Kidney Int. 2017 Mar 15. pii: S0085-2538(17)30025.
    PubMed     Text format     Abstract available


  120. SICARD A, Meas-Yedid V, Rabeyrin M, Koenig A, et al
    Computer-assisted topological analysis of renal allograft inflammation adds to risk evaluation at diagnosis of humoral rejection.
    Kidney Int. 2017 Mar 15. pii: S0085-2538(17)30038.
    PubMed     Text format     Abstract available


  121. MCMAHON GM, Hwang SJ, Clish CB, Tin A, et al
    Urinary metabolites along with common and rare genetic variations are associated with incident chronic kidney disease.
    Kidney Int. 2017 Mar 14. pii: S0085-2538(17)30034.
    PubMed     Text format     Abstract available


  122. PORT FK, Robinson BM, McCullough KP, Morgenstern H, et al
    Predialysis blood pressure on survival in hemodialysis patients.
    Kidney Int. 2017;91:755-756.
    PubMed     Text format    



  123. Charytan DM, Desai M, Mathur M, et al. Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease. Kidney Int. 2016;90:411
    Kidney Int. 2017;91:758.
    PubMed     Text format    


  124. OHNO Y, Kanno Y, Takenaka T
    Letter regarding "Estimated aortic blood pressure based on radial artery tonometry underestimates directly measured aortic blood pressure in patients with advancing chronic kidney disease staging and increasing arterial stiffness".
    Kidney Int. 2017;91:757.
    PubMed     Text format    


  125. LOWENSTEIN J, Grantham JJ
    Residual renal function: a paradigm shift.
    Kidney Int. 2017;91:561-565.
    PubMed     Text format     Abstract available


  126. RAVINDRAN A, Go RS, Fervenza FC, Sethi S, et al
    Thrombotic microangiopathy associated with monoclonal gammopathy.
    Kidney Int. 2017;91:691-698.
    PubMed     Text format     Abstract available


    February 2017
  127. BAGSHAW SM, Wald R
    Strategies for the optimal timing to start renal replacement therapy in critically ill patients with acute kidney injury.
    Kidney Int. 2017 Feb 17. pii: S0085-2538(16)30755.
    PubMed     Text format     Abstract available


  128. XING YF, Cai RM, Lin Q, Ye QJ, et al
    Expansion of polymorphonuclear myeloid-derived suppressor cells in patients with end-stage renal disease may lead to infectious complications.
    Kidney Int. 2017 Feb 16. pii: S0085-2538(16)30756.
    PubMed     Text format     Abstract available


  129. DEKKER MJ, Marcelli D, Canaud BJ, Carioni P, et al
    Impact of fluid status and inflammation and their interaction on survival: a study in an international hemodialysis patient cohort.
    Kidney Int. 2017 Feb 13. pii: S0085-2538(16)30710.
    PubMed     Text format     Abstract available


  130. WEBSTER P, Lightstone L, McKay DB, Josephson MA, et al
    Pregnancy in chronic kidney disease and kidney transplantation.
    Kidney Int. 2017 Feb 13. pii: S0085-2538(16)30748.
    PubMed     Text format     Abstract available


  131. GAROFALO C, Borrelli S, Minutolo R, Chiodini P, et al
    A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30752.
    PubMed     Text format     Abstract available


  132. OELLGAARD J, Gaede P, Rossing P, Persson F, et al
    Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30747.
    PubMed     Text format     Abstract available


  133. TIMMERMANS SA, Abdul-Hamid MA, Vanderlocht J, Damoiseaux JG, et al
    Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30742.
    PubMed     Text format     Abstract available


  134. AL AZZI Y, Daleo J, Dube G
    To Be or not To Be: a rare cause of AKI in a renal allograft.
    Kidney Int. 2017;91:513.
    PubMed     Text format    


  135. KU E, Lipkowitz MS, Appel LJ, Parsa A, et al
    Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.
    Kidney Int. 2017;91:443-450.
    PubMed     Text format     Abstract available


    January 2017
  136. KURELLA TAMURA M, Vittinghoff E, Hsu CY, Tam K, et al
    Loss of executive function after dialysis initiation in adults with chronic kidney disease.
    Kidney Int. 2017 Jan 27. pii: S0085-2538(16)30701.
    PubMed     Text format     Abstract available


  137. HU MC, Shi M, Gillings N, Flores B, et al
    Recombinant alpha-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
    Kidney Int. 2017 Jan 25. pii: S0085-2538(16)30649.
    PubMed     Text format     Abstract available


  138. HAAS M, Mirocha J, Reinsmoen NL, Vo AA, et al
    Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Kidney Int. 2017 Jan 16. pii: S0085-2538(16)30656.
    PubMed     Text format     Abstract available


  139. GARG AX, Suri RS, Eggers P, Finkelstein FO, et al
    Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis.
    Kidney Int. 2017 Jan 13. pii: S0085-2538(16)30647.
    PubMed     Text format     Abstract available


  140. SIRICH TL, Fong K, Larive B, Beck GJ, et al
    Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.
    Kidney Int. 2017 Jan 12. pii: S0085-2538(16)30648.
    PubMed     Text format     Abstract available


  141. LIAO CT, Andrews R, Wallace LE, Khan MW, et al
    Peritoneal macrophage heterogeneity is associated with different peritoneal dialysis outcomes.
    Kidney Int. 2017 Jan 5. pii: S0085-2538(16)30640.
    PubMed     Text format     Abstract available


  142. KOBAYASHI R, Wakui H, Azushima K, Uneda K, et al
    An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model.
    Kidney Int. 2017 Jan 4. pii: S0085-2538(16)30650.
    PubMed     Text format     Abstract available


  143. ASSIS LV, Pereira ER, Sa CB, Guimaraes-Neto I, et al
    Right ventricular perforation by tunneled hemodialysis catheter.
    Kidney Int. 2017;91:255.
    PubMed     Text format    


  144. WYATT CM
    A rose by any other name: is stage 3a chronic kidney disease really a disease?
    Kidney Int. 2017;91:6-8.
    PubMed     Text format     Abstract available


  145. CAPLIN B, Nitsch D
    Urinary biomarkers of tubular injury in chronic kidney disease.
    Kidney Int. 2017;91:21-23.
    PubMed     Text format     Abstract available


  146. HATTORI M
    Hemoglobin target in children with chronic kidney disease: valuable new information.
    Kidney Int. 2017;91:16-18.
    PubMed     Text format     Abstract available


    December 2016
  147. LOCKE JE, Reed RD, Massie A, MacLennan PA, et al
    Obesity increases the risk of end-stage renal disease among living kidney donors.
    Kidney Int. 2016 Dec 29. pii: S0085-2538(16)30613.
    PubMed     Text format     Abstract available


  148. MATHEW RO, Bangalore S, Lavelle MP, Pellikka PA, et al
    Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review.
    Kidney Int. 2016 Dec 28. pii: S0085-2538(16)30625.
    PubMed     Text format     Abstract available


  149. KESKAR V, McArthur E, Wald R, Harel Z, et al
    The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.
    Kidney Int. 2016 Dec 22. pii: S0085-2538(16)30618.
    PubMed     Text format     Abstract available


  150. MUNOZ MENDOZA J, Isakova T, Cai X, Bayes LY, et al
    Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
    Kidney Int. 2016 Dec 22. pii: S0085-2538(16)30622.
    PubMed     Text format     Abstract available


  151. TRIPEPI G, Pannier B, D'Arrigo G, Mallamaci F, et al
    Reappraisal in two European cohorts of the prognostic power of left ventricular mass index in chronic kidney failure.
    Kidney Int. 2016 Dec 20. pii: S0085-2538(16)30611.
    PubMed     Text format     Abstract available


  152. EVENEPOEL P, Behets GJ, Viaene L, D'Haese PC, et al
    Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation.
    Kidney Int. 2016 Dec 17. pii: S0085-2538(16)30607.
    PubMed     Text format     Abstract available


  153. LITJENS NH, Boer K, Zuijderwijk JM, Klepper M, et al
    Natural regulatory T cells from patients with end-stage renal disease can be used for large-scale generation of highly suppressive alloantigen-specific Tregs.
    Kidney Int. 2016 Dec 14. pii: S0085-2538(16)30599.
    PubMed     Text format     Abstract available


  154. SOLEIMANI A, Zarrati Mojarrad M, Bahmani F, Taghizadeh M, et al
    Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects.
    Kidney Int. 2016 Dec 4. pii: S0085-2538(16)30592.
    PubMed     Text format     Abstract available


  155. CARRERO JJ, Grams ME, Sang Y, Arnlov J, et al
    Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality.
    Kidney Int. 2016 Dec 4. pii: S0085-2538(16)30589.
    PubMed     Text format     Abstract available


  156. SCHELLINGER IN, Cordasic N, Panesar J, Buchholz B, et al
    Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease.
    Kidney Int. 2016 Dec 4. pii: S0085-2538(16)30561.
    PubMed     Text format     Abstract available


  157. KIM CS, Bae EH, Ma SK, Kim SW, et al
    The Case | Seizure, ophthalmoplegia, and amnesia in a peritoneal dialysis patient.
    Kidney Int. 2016;90:1389-1390.
    PubMed     Text format    


  158. DAVIES SJ
    Normalizing the peritoneal dialysis dose-have we got it right?
    Kidney Int. 2016;90:1162-1163.
    PubMed     Text format     Abstract available


  159. FARRINGTON K, Davenport A
    Would prescribing target Kt dose adjusted for body surface area improve hemodialysis outcomes?
    Kidney Int. 2016;90:1160-1162.
    PubMed     Text format     Abstract available


  160. WALD R, Perl J
    Extended hours hemodialysis and survival: extended hours, extended evidence?
    Kidney Int. 2016;90:1155-1157.
    PubMed     Text format     Abstract available


  161. LEE MJ, Park JT, Park KS, Kwon YE, et al
    Normal body mass index with central obesity has increased risk of coronary artery calcification in Korean patients with chronic kidney disease.
    Kidney Int. 2016;90:1368-1376.
    PubMed     Text format     Abstract available


  162. WYATT CM, Spence JD
    Folic acid supplementation and chronic kidney disease progression.
    Kidney Int. 2016;90:1144-1145.
    PubMed     Text format     Abstract available


    November 2016
  163. VERVLOET M, Cozzolino M
    Vascular calcification in chronic kidney disease: different bricks in the wall?
    Kidney Int. 2016 Nov 30. pii: S0085-2538(16)30553.
    PubMed     Text format     Abstract available


  164. TANAKA K, Watanabe T, Takeuchi A, Ohashi Y, et al
    Cardiovascular events and death in Japanese patients with chronic kidney disease.
    Kidney Int. 2016 Nov 21. pii: S0085-2538(16)30541.
    PubMed     Text format     Abstract available


  165. RHEAULT MN, Molony JT, Nevins T, Herzog CA, et al
    Hemoglobin of 12 g/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis.
    Kidney Int. 2016 Nov 16. pii: S0085-2538(16)30539.
    PubMed     Text format     Abstract available


  166. WYATT CM, Drueke TB
    HIF stabilization by prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease.
    Kidney Int. 2016;90:923-925.
    PubMed     Text format     Abstract available


  167. ELRGGAL ME, Kotb GA, Elghitani A, Zyada R, et al
    Coronary revascularization in chronic kidney disease patients, external validity of meta-analysis results.
    Kidney Int. 2016;90:1131-1132.
    PubMed     Text format    


  168. READY AR, Nath J, Milford DV, Adu D, et al
    Establishing sustainable kidney transplantation programs in developing world countries: a 10-year experience.
    Kidney Int. 2016;90:916-920.
    PubMed     Text format    


    October 2016
  169. HSU CY, Xie D, Waikar SS, Bonventre JV, et al
    Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.
    Kidney Int. 2016 Oct 28. pii: S0085-2538(16)30486.
    PubMed     Text format     Abstract available


  170. CHERUKURI A, Salama AD, Carter CR, Landsittel D, et al
    Reduced human transitional B cell T1/T2 ratio is associated with subsequent deterioration in renal allograft function.
    Kidney Int. 2016 Oct 28. pii: S0085-2538(16)30481.
    PubMed     Text format     Abstract available


  171. MADUELL F, Ramos R, Varas J, Martin-Malo A, et al
    Hemodialysis patients receiving a greater Kt dose than recommended have reduced mortality and hospitalization risk.
    Kidney Int. 2016 Oct 22. pii: S0085-2538(16)30469.
    PubMed     Text format     Abstract available


  172. BROWN EA, Finkelstein FO, Iyasere OU, Kliger AS, et al
    Peritoneal or hemodialysis for the frail elderly patient, the choice of 2 evils?
    Kidney Int. 2016 Oct 20. pii: S0085-2538(16)30474.
    PubMed     Text format     Abstract available


  173. GEWIN L, Zent R, Pozzi A
    Progression of chronic kidney disease: too much cellular talk causes damage.
    Kidney Int. 2016 Oct 20. pii: S0085-2538(16)30473.
    PubMed     Text format     Abstract available


  174. BANSAL N, McCulloch CE, Lin F, Robinson-Cohen C, et al
    Different components of blood pressure are associated with increased risk of atherosclerotic cardiovascular disease versus heart failure in advanced chronic kidney disease.
    Kidney Int. 2016 Oct 4. pii: S0085-2538(16)30436.
    PubMed     Text format     Abstract available


  175. GRAHAM-BROWN MP, March DS, Churchward DR, Stensel DJ, et al
    Novel cardiac nuclear magnetic resonance method for noninvasive assessment of myocardial fibrosis in hemodialysis patients.
    Kidney Int. 2016;90:835-44.
    PubMed     Text format     Abstract available


  176. SHROFF GR, Raggi P
    Exploring the elusive link between subclinical fibrosis and clinical events in end-stage renal disease: does cardiac magnetic resonance imaging hold the key?
    Kidney Int. 2016;90:729-32.
    PubMed     Text format     Abstract available


  177. YADAV AK, Kumar V, Sinha N, Jha V, et al
    APOL1 risk allele variants are absent in Indian patients with chronic kidney disease.
    Kidney Int. 2016;90:906-7.
    PubMed     Text format    


  178. VAN EERDE AM, Krediet CT, Rookmaaker MB, van Reekum FE, et al
    Pre-pregnancy advice in chronic kidney disease: do not forget genetic counseling.
    Kidney Int. 2016;90:905-6.
    PubMed     Text format    


    September 2016
  179. TAMPE B, Steinle U, Tampe D, Carstens JL, et al
    Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression.
    Kidney Int. 2016 Sep 27. pii: S0085-2538(16)30428.
    PubMed     Text format     Abstract available


  180. ZHANG Q, Liu L, Lin W, Yin S, et al
    Rhein reverses Klotho repression via promoter demethylation and protects against kidney and bone injuries in mice with chronic kidney disease.
    Kidney Int. 2016 Sep 27. pii: S0085-2538(16)30426.
    PubMed     Text format     Abstract available


  181. MATSUSHITA K, Chen J, Sang Y, Ballew SH, et al
    Risk of end-stage renal disease in Japanese patients with chronic kidney disease increases proportionately to decline in estimated glomerular filtration rate.
    Kidney Int. 2016 Sep 22. pii: S0085-2538(16)30429.
    PubMed     Text format     Abstract available


  182. SUGATANI T, Agapova OA, Fang Y, Berman AG, et al
    Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.
    Kidney Int. 2016 Sep 22. pii: S0085-2538(16)30425.
    PubMed     Text format     Abstract available


  183. SOTO K, Campos P, Pinto I, Rodrigues B, et al
    The risk of chronic kidney disease and mortality are increased after community-acquired acute kidney injury.
    Kidney Int. 2016 Sep 19. pii: S0085-2538(16)30356.
    PubMed     Text format     Abstract available


  184. EL-KATEB S, Sridharan S, Farrington K, Fan S, et al
    A single weekly Kt/Vurea target for peritoneal dialysis patients does not provide an equal dialysis dose for all.
    Kidney Int. 2016 Sep 18. pii: S0085-2538(16)30400.
    PubMed     Text format     Abstract available


  185. AMARAL S, Sayed BA, Kutner N, Patzer RE, et al
    Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease.
    Kidney Int. 2016 Sep 18. pii: S0085-2538(16)30401.
    PubMed     Text format     Abstract available


  186. EVENEPOEL P, Bover J, Torres PU
    Parathyroid hormone metabolism and signaling in health and chronic kidney disease.
    Kidney Int. 2016 Sep 18. pii: S0085-2538(16)30402.
    PubMed     Text format     Abstract available


  187. DONG J, Dong Y, Chen Z, Mitch WE, et al
    The pathway to muscle fibrosis depends on myostatin stimulating the differentiation of fibro/adipogenic progenitor cells in chronic kidney disease.
    Kidney Int. 2016 Sep 18. pii: S0085-2538(16)30404.
    PubMed     Text format     Abstract available


  188. PERGOLA PE, Spinowitz BS, Hartman CS, Maroni BJ, et al
    Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease.
    Kidney Int. 2016 Sep 17. pii: S0085-2538(16)30357.
    PubMed     Text format     Abstract available


  189. MARSHALL MR
    Observations of twice a week hemodialysis.
    Kidney Int. 2016 Sep 16. pii: S0085-2538(16)30380.
    PubMed     Text format     Abstract available


  190. HANNEDOUCHE T, Roth H, Krummel T, London GM, et al
    Multiphasic effects of blood pressure on survival in hemodialysis patients.
    Kidney Int. 2016;90:674-84.
    PubMed     Text format     Abstract available


    August 2016
  191. CHEIKH HASSAN HI, Tang M, Djurdjev O, Langsford D, et al
    Infection in advanced chronic kidney disease leads to increased risk of cardiovascular events, end-stage kidney disease and mortality.
    Kidney Int. 2016 Aug 30. pii: S0085-2538(16)30350.
    PubMed     Text format     Abstract available


  192. KIENEKER LM, Bakker SJ, de Boer RA, Navis GJ, et al
    Low potassium excretion but not high sodium excretion is associated with increased risk of developing chronic kidney disease.
    Kidney Int. 2016 Aug 26. pii: S0085-2538(16)30349.
    PubMed     Text format     Abstract available


  193. RIVARA MB, Adams SV, Kuttykrishnan S, Kalantar-Zadeh K, et al
    Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal disease.
    Kidney Int. 2016 Aug 20. pii: S0085-2538(16)30322.
    PubMed     Text format     Abstract available


  194. MATHEW A, Obi Y, Rhee CM, Chen JL, et al
    Treatment frequency and mortality among incident hemodialysis patients in the United States comparing incremental with standard and more frequent dialysis.
    Kidney Int. 2016 Aug 12. pii: S0085-2538(16)30299.
    PubMed     Text format     Abstract available


  195. CEJKA D, Parada-Rodriguez D, Pichler S, Marculescu R, et al
    Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease.
    Kidney Int. 2016 Aug 12. pii: S0085-2538(16)30308.
    PubMed     Text format     Abstract available


  196. RUTHERFORD E, Talle MA, Mangion K, Bell E, et al
    Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping.
    Kidney Int. 2016 Aug 5. pii: S0085-2538(16)30298.
    PubMed     Text format     Abstract available


  197. BRIER ME, Gaweda AE
    Artificial intelligence for optimal anemia management in end-stage renal disease.
    Kidney Int. 2016;90:259-61.
    PubMed     Text format     Abstract available


  198. MORADI H, Said HM
    Functional thiamine deficiency in end-stage renal disease: malnutrition despite ample nutrients.
    Kidney Int. 2016;90:252-4.
    PubMed     Text format     Abstract available


  199. CHEN TK, Estrella MM
    APOL1 risk variants and death among African American hemodialysis patients: survival of the fittest?
    Kidney Int. 2016;90:249-52.
    PubMed     Text format     Abstract available


  200. RIGATTO C, Komenda P, Tangri N
    CABG or PCI: which is better for revascularization of coronary artery disease in chronic kidney disease?
    Kidney Int. 2016;90:257-9.
    PubMed     Text format     Abstract available


  201. BATAL I, Crew RJ
    The Case | An 80-year-old kidney transplant recipient with malaise and early allograft dysfunction.
    Kidney Int. 2016;90:455-6.
    PubMed     Text format    


    July 2016
  202. SINGH S, Grabner A, Yanucil C, Schramm K, et al
    Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.
    Kidney Int. 2016 Jul 22. pii: S0085-2538(16)30236.
    PubMed     Text format     Abstract available


  203. WETMORE JB, Guo H, Liu J, Collins AJ, et al
    The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis.
    Kidney Int. 2016 Jul 14. pii: S0085-2538(16)30211.
    PubMed     Text format     Abstract available


  204. CARLSEN RK, Peters CD, Khatir DS, Laugesen E, et al
    Estimated aortic blood pressure based on radial artery tonometry underestimates directly measured aortic blood pressure in patients with advancing chronic kidney disease staging and increasing arterial stiffness.
    Kidney Int. 2016 Jul 8. pii: S0085-2538(16)30205.
    PubMed     Text format     Abstract available


  205. HU YW
    Chinese herbal medicine use and risk of end-stage renal disease in patients with chronic kidney disease: is there an immortal time bias?
    Kidney Int. 2016;90:227-8.
    PubMed     Text format    


  206. WYATT CM, Cattran DC
    Intensive glycemic control and the risk of end-stage renal disease: an ADVANCE in the management of diabetes?
    Kidney Int. 2016;90:8-10.
    PubMed     Text format     Abstract available


  207. DE RECHTER S, Levtchenko E, Evenepoel P, Mekahli D, et al
    The Case | Hypercalcemia in a child with chronic kidney disease.
    Kidney Int. 2016;90:233-4.
    PubMed     Text format    


    June 2016
  208. WEIR MR, Bakris GL, Gross C, Mayo MR, et al
    Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Kidney Int. 2016 Jun 24. pii: S0085-2538(16)30186.
    PubMed     Text format     Abstract available


  209. HALLAN SI, Ovrehus MA, Romundstad S, Rifkin D, et al
    Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway.
    Kidney Int. 2016 Jun 22. pii: S0085-2538(16)30170.
    PubMed     Text format     Abstract available


  210. ZHOU Q, Bajo MA, Del Peso G, Yu X, et al
    Preventing peritoneal membrane fibrosis in peritoneal dialysis patients.
    Kidney Int. 2016 Jun 7. pii: S0085-2538(16)30138.
    PubMed     Text format     Abstract available


  211. BARBIERI C, Molina M, Ponce P, Tothova M, et al
    An international observational study suggests that artificial intelligence for clinical decision support optimizes anemia management in hemodialysis patients.
    Kidney Int. 2016 Jun 2. pii: S0085-2538(16)30132.
    PubMed     Text format     Abstract available


  212. CHEN T, Cleland B, Nankivell BJ
    The Case | Rapidly progressing polyneuropathy in a dialysis patient.
    Kidney Int. 2016;89:1409-10.
    PubMed     Text format    


  213. WHEELER DC, Kasiske BL
    Statins for hemodialysis patients with diabetes? Long-term follow-up endorses the original conclusions of the 4D Study.
    Kidney Int. 2016;89:1189-91.
    PubMed     Text format     Abstract available


  214. JESUDASON D, Clifton P
    Limitations of using the Chronic Kidney Disease-Epidemiology Collaboration equation for measuring renal function in obese populations.
    Kidney Int. 2016;89:1400-1.
    PubMed     Text format    


  215. HAGE V, Pelletier S, Fouque D
    No apparent link between serum Klotho and phosphate in human chronic kidney disease.
    Kidney Int. 2016;89:1399-400.
    PubMed     Text format    


  216. ENDRE ZH, Fernando M
    Unlocking the code: mining the urinary proteome after renal transplantation.
    Kidney Int. 2016;89:1183-5.
    PubMed     Text format     Abstract available


  217. MASSY ZA, Drueke TB
    Activin receptor IIA ligand trap in chronic kidney disease: 1 drug to prevent 2 complications-or even more?
    Kidney Int. 2016;89:1180-2.
    PubMed     Text format     Abstract available


  218. WYATT CM, Shineski M, Chertow GM, Bangalore S, et al
    ISCHEMIA in chronic kidney disease: improving the representation of patients with chronic kidney disease in cardiovascular trials.
    Kidney Int. 2016;89:1178-9.
    PubMed     Text format     Abstract available


    May 2016
  219. CHARYTAN DM, Desai M, Mathur M, Stern NM, et al
    Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease.
    Kidney Int. 2016 May 31. pii: S0085-2538(16)30126.
    PubMed     Text format     Abstract available


  220. ZHANG F, Masania J, Anwar A, Xue M, et al
    The uremic toxin oxythiamine causes functional thiamine deficiency in end-stage renal disease by inhibiting transketolase activity.
    Kidney Int. 2016 May 14. pii: S0085-2538(16)30057.
    PubMed     Text format     Abstract available


  221. MATHEW AT, Fishbane S, Obi Y, Kalantar-Zadeh K, et al
    Preservation of residual kidney function in hemodialysis patients: reviving an old concept.
    Kidney Int. 2016 May 12. pii: S0085-2538(16)30054.
    PubMed     Text format     Abstract available


  222. MARCELLI D, Bayh I, Merello JI, Ponce P, et al
    Dynamics of the erythropoiesis stimulating agent resistance index in incident hemodiafiltration and high-flux hemodialysis patients.
    Kidney Int. 2016 May 10. pii: S0085-2538(16)30056.
    PubMed     Text format     Abstract available


  223. ROMANOWSKI K, Clark EG, Levin A, Cook VJ, et al
    Tuberculosis and chronic kidney disease: an emerging global syndemic.
    Kidney Int. 2016 May 10. pii: S0085-2538(16)30053.
    PubMed     Text format     Abstract available


  224. SALAND JM, Satlin LM, Zalsos-Johnson J, Cremers S, et al
    Impaired postprandial lipemic response in chronic kidney disease.
    Kidney Int. 2016 May 7. pii: S0085-2538(16)30011.
    PubMed     Text format     Abstract available


  225. MA L, Langefeld CD, Comeau ME, Bonomo JA, et al
    APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.
    Kidney Int. 2016 May 5. pii: S0085-2538(16)30012.
    PubMed     Text format     Abstract available


  226. CARRERO JJ, Johansen KL, Lindholm B, Stenvinkel P, et al
    Screening for muscle wasting and dysfunction in patients with chronic kidney disease.
    Kidney Int. 2016 May 5. pii: S0085-2538(16)30003.
    PubMed     Text format     Abstract available


    April 2016
  227. CHESNAYE NC, Schaefer F, Groothoff JW, Bonthuis M, et al
    Mortality risk in European children with end-stage renal disease on dialysis.
    Kidney Int. 2016 Apr 13. pii: S0085-2538(16)00366.
    PubMed     Text format     Abstract available


  228. NEU AM, Richardson T, Lawlor J, Stuart J, et al
    Implementation of standardized follow-up care significantly reduces peritonitis in children on chronic peritoneal dialysis.
    Kidney Int. 2016 Apr 13. pii: S0085-2538(16)00365.
    PubMed     Text format     Abstract available


  229. BENGHANEM GHARBI M, Elseviers M, Zamd M, Belghiti Alaoui A, et al
    Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid "over"- and "under"-diagnosis of CKD.
    Kidney Int. 2016 Apr 13. pii: S0085-2538(16)00369.
    PubMed     Text format     Abstract available


  230. ZHANG L, Lee G, Liu X, Pascoe EM, et al
    Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.
    Kidney Int. 2016 Apr 8. pii: S0085-2538(16)00363.
    PubMed     Text format     Abstract available


  231. GILL J, Dong J, Rose C, Gill JS, et al
    The risk of allograft failure and the survival benefit of kidney transplantation are complicated by delayed graft function.
    Kidney Int. 2016 Apr 5. pii: S0085-2538(16)00324.
    PubMed     Text format     Abstract available


    March 2016
  232. CARRILLO-LOPEZ N, Panizo S, Alonso-Montes C, Roman-Garcia P, et al
    Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease.
    Kidney Int. 2016 Mar 24. pii: S0085-2538(16)00314.
    PubMed     Text format     Abstract available


  233. AGAPOVA OA, Fang Y, Sugatani T, Seifert ME, et al
    Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease.
    Kidney Int. 2016 Mar 11. pii: S0085-2538(16)00290.
    PubMed     Text format     Abstract available


  234. SIGDEL TK, Gao Y, He J, Wang A, et al
    Mining the human urine proteome for monitoring renal transplant injury.
    Kidney Int. 2016 Mar 4. pii: S0085-2538(16)00288.
    PubMed     Text format     Abstract available


    February 2016
  235. LEE T, Derebail VK, Kshirsagar AV, Chung Y, et al
    Patients with primary membranous nephropathy are at high risk of cardiovascular events.
    Kidney Int. 2016 Feb 26. pii: S0085-2538(16)00275.
    PubMed     Text format     Abstract available


  236. TAN BK, Yu Z, Fang W, Lin A, et al
    Longitudinal bioimpedance vector plots add little value to fluid management of peritoneal dialysis patients.
    Kidney Int. 2016;89:487-97.
    PubMed     Text format     Abstract available


  237. JING YJ, Ni JW, Ding FH, Fang YH, et al
    p-Cresyl sulfate is associated with carotid arteriosclerosis in hemodialysis patients and promotes atherogenesis in apoE-/- mice.
    Kidney Int. 2016;89:439-49.
    PubMed     Text format     Abstract available


    January 2016
  238. BARBOUR SJ, Espino-Hernandez G, Reich HN, Coppo R, et al
    The MEST score provides earlier risk prediction in lgA nephropathy.
    Kidney Int. 2016;89:167-75.
    PubMed     Text format     Abstract available


  239. SELAMET U, Tighiouart H, Sarnak MJ, Beck G, et al
    Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: The Modification of Diet in Renal Disease Study.
    Kidney Int. 2016;89:176-84.
    PubMed     Text format     Abstract available


  240. DAVENPORT A, Peters SA, Bots ML, Canaud B, et al
    Higher convection volume exchange with online hemodiafiltration is associated with survival advantage for dialysis patients: the effect of adjustment for body size.
    Kidney Int. 2016;89:193-9.
    PubMed     Text format     Abstract available


    July 2015
  241. RABASCO C, Cavero T, Roman E, Rojas-Rivera J, et al
    Effectiveness of mycophenolate mofetil in C3 glomerulonephritis.
    Kidney Int. 2015 Jul 29. doi: 10.1038/ki.2015.
    PubMed     Text format     Abstract available


  242. CAMPBELL SB, Clayton PA
    A scoring system to screen elderly potential kidney transplant recipients: a simple tool for a complex task.
    Kidney Int. 2015;88:5-6.
    PubMed     Text format     Abstract available


    June 2015
  243. BERTHELOT L, Robert T, Vuiblet V, Tabary T, et al
    Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Kidney Int. 2015 Jun 10. doi: 10.1038/ki.2015.
    PubMed     Text format     Abstract available


    May 2015
  244. SIM JJ, Bhandari SK, Shi J, Reynolds K, et al
    Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension.
    Kidney Int. 2015 May 6. doi: 10.1038/ki.2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: